ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand Read more about ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand
New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development Read more about New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester Read more about ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester
ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe Read more about ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
ICON Acquires Assets of Qualia Clinical Services, Inc. Read more about ICON Acquires Assets of Qualia Clinical Services, Inc.
ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility Read more about ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility
ICON Announces Appointment of Dr. Anthony J. Murphy to the Board of Directors Read more about ICON Announces Appointment of Dr. Anthony J. Murphy to the Board of Directors
ICON Completes CAP Accreditation of its Central Laboratories in Singapore and India Read more about ICON Completes CAP Accreditation of its Central Laboratories in Singapore and India
